Clinical trial
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
NCT00246337 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00246337 |
|---|---|
| Title | A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) |
| Official title | A Multicenter, Double-Blind, Placebo and Active-Controlled, Dose-Finding Study of MK0974 in the Treatment of Acute Migraine |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | Comparator: Placebo, MK0974, Rizatriptan |
| Enrollment | 420 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Oct 31, 2005 |
| Last update posted | Nov 2, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: